Home » Biodel Completes Two Pivotal Phase III VIAject Clinical Trials
Biodel Completes Two Pivotal Phase III VIAject Clinical Trials
Biodel Inc. said its two pivotal Phase III VIAject clinical trials are now complete, with the last study patient visit on July 14.
RTTNews
RTTNews
Upcoming Events
-
07May
-
14May
-
30May